• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,247.49 140.64
( 0.19%)
Global Indices
Nasdaq
46,689.37 163.69
(0.35%)
Dow Jones
6,632.05 28.36
(0.43%)
Hang Seng
53,529.44 115.76
(0.22%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
92.68 -0.34
(-0.37%)
EUR-INR
106.73 -0.59
(-0.55%)
GBP-INR
122.22 -0.80
(-0.65%)
JPY-INR
0.58 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Kerala Ayurveda Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530163
INE817B01025
34.6362913
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
278.16
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Hindustan Unilever board OKs Rs 2,000-cr capex for capacity expansion
Feb 19,2026
The proposed investment is in line with the company’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand spaces, including premium skin care and hair care and personal care & home care liquids.

Priya Nair, CEO and managing director, HUL, said: 'This investment reflects our strategic focus on scaling our brands and creating categories of the future to meet evolving consumer needs. It also underscores our commitment to building a resilient, technology-enabled supply chain that delivers superior value to consumers.'

Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.

The company's consolidated net profit zoomed 120.91% to Rs 6,603 crore on 5.74% jump in revenue from operations to Rs 16,235 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.90% to end at Rs 2279.50 on the BSE.